|Articles|June 1, 1997

June 1997
Volume 3
Issue 6

Cost of Illness Studies for Schizophrenia: Components, Benefits, Results, and Implications

Author(s)Laura A. Genduso, PharmD, Jane Castelli Haley, MBA

Download PDF: Cost of Illness Studies for Schizophrenia: Components, Benefits, Results, and Implications

Articles in this issue

about 29 years ago

Article

Issues of Medical Necessity: A Medical Director's Guide to Good Faith Adjudication

about 29 years ago

Article

Asthma Treatment Costs Using Inhaled Corticosteroids

about 29 years ago

Article

Costs, True Costs, and Whose Costs in Economic Analyses in Medicine?

about 29 years ago

Article

The Challenge of Integrating Monoclonal Antibodies into the Current Healthcare System

about 29 years ago

Article

Prostate Cancer Screening

about 29 years ago

Article

Breast Reconstruction After Mastectomy

about 29 years ago

Article

Exploring Self-Care and Wellness: A Model for Pharmacist Compensation by Managed Care Organizations

about 29 years ago

Article

Breast-Feeding and Managed Care

about 29 years ago

Article

Correspondence regarding, "The Political Economy of Capitated Managed Care"

about 29 years ago

Article

Economic Advantages of Breast-Feeding in an HMO Setting: A Pilot Study

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Cost of Illness Studies for Schizophrenia: Components, Benefits, Results, and Implications

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology

Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD

Ontada Analysis Finds GLP-1 RA Use Linked to Improved Survival in Patients With Cancer

Orexin Agonist Shows Promise for Treating Narcolepsy, Hypersomnia: Richard Bogan, MD

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs